Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korea Growth Investment Corp (K-Growth) is a specialized fund-of-funds management company based in Seoul, South Korea, that plays a pivotal role in the nation's venture capital ecosystem. Established in 2016, the firm manages the Korea Growth Fund, a large-scale policy fund designed to provide liquidity and support to small and medium-sized enterprises (SMEs) and innovative startups. K-Growth operates by committing capital to various sub-funds managed by private venture capital and private equity firms, which in turn invest in high-growth sectors such as biotechnology, healthcare, and information technology. The organization is a key driver of the Korean life sciences sector, facilitating the development of new therapies and medical technologies by ensuring a steady flow of investment capital to domestic biotech firms. In addition to venture growth, K-Growth manages specialized vehicles for corporate restructuring and social impact, bridging the gap between government policy and private market innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korea Growth Fund.